The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
about
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanismsFOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyNucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.Role of solute carrier transporters in pancreatic cancer: a review.Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216.Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer.Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine.Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.Solute carrier transporters: potential targets for digestive system neoplasms.A Decision Tree Based Classifier to Analyze Human Ovarian Cancer cDNA Microarray Datasets.A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma.Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.Emerging Roles of Nucleoside Transporters.Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
P2860
Q26749468-1192DABE-4B94-480A-9005-B215DDEF3A24Q26851060-1BF6563B-8C7A-47D9-9487-89BE6B0CCB08Q35066350-F289017E-259B-44CE-A15E-20CAD2E662CDQ37685797-B04A6453-B608-458D-875D-CECDCFC159AFQ38236028-D7A2DC9A-9B35-472E-B867-9ED5BA6D3632Q38619018-67C0BE85-047A-41B1-8A8E-46D1F44D8806Q38749227-3556964B-4E16-41A6-9FBE-00C0E1E6D101Q38850605-E07B0B0C-7C68-40F0-A78C-B352FDCB8F66Q45220444-F845D88E-D647-4883-952C-939ECEEAC080Q45249684-5B3BD983-8977-4F51-8319-9888B7BB8DE0Q49667930-75C2E837-6CD2-45F9-AC0E-934F867E41C7Q50780244-0C3D17A0-EF8C-424C-A774-947618F5B089Q52603515-A8460554-8C0B-41A8-9D13-3B722CE514EEQ55030406-13610D78-ACED-4724-8A8E-8955B4DBCA66Q55384452-E341FB49-D5A3-4BE2-83E0-341E3C6F2B63Q57175017-397C0E72-6AE1-4636-AC42-DCA3D0843B92
P2860
The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The association between the ex ...... rognosis of pancreatic cancer.
@en
The association between the ex ...... rognosis of pancreatic cancer.
@nl
type
label
The association between the ex ...... rognosis of pancreatic cancer.
@en
The association between the ex ...... rognosis of pancreatic cancer.
@nl
prefLabel
The association between the ex ...... rognosis of pancreatic cancer.
@en
The association between the ex ...... rognosis of pancreatic cancer.
@nl
P2093
P2860
P50
P1476
The association between the ex ...... prognosis of pancreatic cancer
@en
P2093
Beatrice Mohelnikova-Duchonova
Bohuslav Melichar
Eva Honsova
Jan Hlavsa
Jan Mazanec
Matej Kocik
Veronika Brynychova
Zdenek Kala
P2860
P2888
P304
P356
10.1007/S00280-013-2246-2
P577
2013-08-11T00:00:00Z